Diagnostic and Treatment Services
We offer a complete range of diagnostic and treatment services for patients
with thoracic malignancies, including:
- Consultations for newly diagnosed and recurrent cancers
- New therapies for all stages of cancer
- Diagnostic ultrasound, MRI and CT scan
- Thoracic Pathology
- Minimally invasive surgical staging with techniques such as: video assisted
thoracoscopy (VATS), laparoscopy and mediastinoscopy
- VATS Lobectomy
- Complex bronchoplastic, angioplastic and chest wall resections
- Combination/Multimodality therapies (chemoradiation followed by surgery)
- Laser and stent therapy
- 3-D conformal radiotherapy
- Hyperfractionated radiotherapy
- Intensity Modulated Radiation
- Specialized treatment for patients with advanced and high-risk lung cancer,
- Treatment of metastatic disease
- Newest clinical trials, investigative drugs and experimental techniques
- Individual and family psychological counseling
Chemotherapy and New Therapeutics
Members of the Thoracic Oncology program have taken leading roles in the development
of new drugs and drug combinations for the treatment of thoracic malignancies. Our center offers access to some of the most important new drugs in development for the treatment of lung cancer and other thoracic cancers. These trials test a variety of approaches, including the evaluation of new drugs for lung cancer as well as potentially better ways of using old drugs. These new drugs contain different mechanisms of action than previously used anti-cancer drugs. UMGCC has pioneered a number of treatments for locally advanced and advanced lung cancer. Other clinical trials in lung cancer include new drugs for initial therapy as well as second and subsequent therapies.
The University of Maryland is a founding member of the Cancer and Leukemia Group
B (CALGB), one of the major NCI funded national cancer research organizations.
Members of the Thoracic Oncology Program are leading national studies of new
therapeutics and approaches through CALGB. Members of the program have also
been leaders in research to minimize the side effects of therapy as well as
Minimally Invasive Surgical Techniques
Members of our staff have pioneered minimally invasive surgical techniques,
surgical staging. This new procedure is a more accurate method of defining
the spread and extent of cancer of the lung and the esophagus, the fastest growing
category of cancer in the United States. Using this minimally invasive surgical
method, physicians can more effectively tailor treatment to the needs of the
individual patient, helping to select which patients will benefit the most from
aggressive therapy and improving outcomes.
The Radiation Oncology Department offers the most modern equipment as well
as the most experienced treatment planning. New approaches to radiation therapy
including Gamma Knife treatment of
brain metastases, 3-dimensional treatment planning, and intensity modulated
radiotherapy (IMRT) were pioneered at the University of Maryland. We were the
first academic medical program in the region to offer the fully-integrated Trilogy™
System linear accelerator, which combines the most advanced imaging and
treatment technologies and can be used to deliver the widest range of external
beam radiotherapies available.
The University is also a full member of the Radiation Therapy Oncology Group
(RTOG). Members of the program are prominent in RTOG as national investigators
of new approaches integrating radiation in the management of thoracic malignancies.
Would you like to schedule an appointment?
If you have a patient who would benefit from the expertise and treatment we
offer, call the Thoracic Oncology Nurse Coordinator to schedule and appointment:
(410) 328-6366 or 1-800-888-8823.
Patients with metastatic disease should call (410) 328-7904 or 1-800-888-8823.
This page was last updated: April 8, 2015